pharmaceutical conglomerate
Scope
Date
~
-
Leadership & Management
HD Hyundai President Chung to deliver keynote at CES 2024
South Korea's No. 1 shipbuilding group’s heir apparent Chung Ki-sun will deliver a keynote speech at the world’s biggest consumer techno...
Oct 24, 2023 (Gmt+09:00)
-
Robotics
Hankook & Company to expand to robotics with Neubility
South Korea’s Hankook & Company Group, formerly Hankook Tire Group, is expanding to robotics to raise its future competitiveness.The gro...
Oct 23, 2023 (Gmt+09:00)
-
Leadership & Management
SK Group needs agility to survive disruptions: chairman
South Korea's No. 2 conglomerate SK Group needs agile responses to rapidly changing business circumstances amid global geopolitical crises, C...
Oct 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis releases Soliris biosimilar in Europe
Samsung Bioepis Co., a biopharmaceutical research and development unit under South Korea's Samsung Group, is rolling out its latest product Epysqli,...
Oct 19, 2023 (Gmt+09:00)
-
Corporate strategy
Hanwha Group chair calls for startup-like entrepreneurial spirit
South Korea’s Hanwha Group Chairman Kim Seung-youn on Monday urged the defense-to-financial conglomerate to revive the bold innovations of its...
Oct 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biologics partners with Indian company for CDMO
Prestige Biologics Co., a South Korean biopharmaceutical contract development and manufacturing organization (CDMO) company, is expanding its CDMO b...
Sep 22, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
SK Chemicals to sell pharmaceutical unit to Glenwood PE
SK Chemicals Co., a South Korean plastic materials producer, is in exclusive talks with Seoul-based Glenwood Private Equity to sell its pharmaceutic...
Sep 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Science joins race to develop Wegovy competitor
Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...
Sep 13, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
IMM PE invites potential buyers for Genuone worth $752 mn
South Korea’s top-tier contract drugmaker Genuone Sciences Inc. with an estimated value of up to 1 trillion won ($752 million) is smooth saili...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio to sell dementia drug AR1001 in China with partner
South Korea's clinical-stage biotech company AriBio Co. on Wednesday said it signed a memorandum of understanding on strategic cooperation with Chin...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong gets patent of Nabota as migraine drug in US
South Korea's Daewoong Pharmaceutical Co. announced on Thursday that it has received a patent from the US Patent and Trademark Office for the use of...
Sep 07, 2023 (Gmt+09:00)
-
Korean startups
LG seeks outside innovators' ideas on new growth drivers at Superstart Day
LG Group, South Korea’s fourth-largest business group, is actively embracing collaboration with outside innovators to foster its new growth dr...
Sep 07, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
Hanwha vice chair pitches submarines to Polish president
Hanwha Group Vice Chairman Kim Dong-kwan is stepping up efforts to win Poland's high-profile submarine project worth an estimated 3 trillion won ($2...
Sep 07, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Fosun to cash out of K-beauty firm Nature&Nature for $38 mn
Fosun Group, a debt-laden Chinese conglomerate, is seeking to cash out of its entire stake in Nature&Nature Co. for up to 50 billion won ($37.8 ...
Aug 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong applies for approval of Envlo in Saudi Arabia
South Korea's Daewoong Pharmaceutical Co. announced on Friday that it has submitted an application for regulatory approval of its new diabetes treat...
Aug 25, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to release Stelara biosimilar in US from March 2025
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it has completed a patent agreement with Johnson & Johnson, the m...
Aug 25, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB signs with Japan's OSCL for exclusive supply of C-Trelin ingredient
South Korea's pharmaceutical company HLB Therapeutics Co. announced on Thursday that it has entered into a business agreement with Japan's Osaka Syn...
Aug 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Ildong Pharma to export high blood pressure treatment to China
South Korea's Ildong Pharmaceutical Co. on Tuesday said it will export benidipine hydrochloride, a raw material used in the treatment of high blood ...
Aug 22, 2023 (Gmt+09:00)
-
Business & Politics
Samsung Securities decides not to rejoin Korea’s top business lobby
Samsung Securities Co., in a surprise move, has decided not to rejoin South Korea’s top business lobby, the Federation of Korean Industries (F...
Aug 22, 2023 (Gmt+09:00)
-
Corporate investment
LG bets big on promising technologies for future growth
LG Group, South Korea’s fourth-largest conglomerate, is accelerating its investment in promising tech companies across the world despite the l...
Aug 17, 2023 (Gmt+09:00)
-
Business & Politics
Korea’s Big Four conglomerates likely to regain FKI membership
South Korea’s four largest business conglomerates – Samsung, Hyundai Motor, SK and LG – will likely return as members of the count...
Aug 09, 2023 (Gmt+09:00)
-
Business & Politics
Bullet maker Poongsan chief Ryu’s new role: Korea’s top business lobbyist
Jin Roy Ryu, chairman of South Korea’s leading copper smelter and defense equipment maker Poongsan Corp., has been chosen to lead the ...
Aug 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Dongwha Pharm to buy Vietnamese pharmacy chain at $30 mn
South Korea's Dongwha Pharm announced on Thursday that it signed an agreement to acquire a 51% stake in Trung Son Pharma, a leading pharmacy chain i...
Aug 04, 2023 (Gmt+09:00)
-
Bio & Pharma
IMM PE seeks to sell Korean contract drugmaker at $784 mn
IMM Private Equity has put a South Korean contract drugmaker on the market for up to 1 trillion won ($784 million) in a deal likely to attract major...
Jul 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to develop obesity drug customized for S.Korean
South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...
Jul 31, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Hanwha Group puts savings bank on market, a clear succession path
Hanwha Group, South Korea’s chemicals-to-defense conglomerate, has put its non-core financial unit Hanwha Savings Bank up for sale, in a move ...
Jul 28, 2023 (Gmt+09:00)
-
Logistics
CJ Logistics to enter global pharmaceutical transportation market
South Korea’s CJ Logistics on Wednesday said it obtained the certification CEIV Pharma, or the Center of Excellence for Independent Validators...
Jul 26, 2023 (Gmt+09:00)
-
Korean stock market
POSCO affiliates’ shares surge; market cap rises threefold in 5 years
Shares of POSCO Group affiliates are flying high with the steelmaker rapidly transforming into a battery materials manufacturer, riding the industry...
Jul 24, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Blackstone seeks medicine distributor sale for 1st Korea exit
Blackstone Inc. has embarked on the process of selling South Korea’s largest medicine wholesaler Geo-Young Corp., a deal estimated at up to $1...
Jul 05, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma inks $90mn deal for blood products in Brazil
South Korea's GC Biopharma Corp. on Monday announced on Monday that it has a supply contract with Blau Farmacêutica, a Brazilian pharmaceutica...
Jul 03, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand